PFSI PennyMac stock rises 171 percent despite Q4 2025 EPS landing 40 percent below analyst forecasts Adaptive Bio ADPT Stock Market Risk 232 20260427 Biogen Inc BIIB Structural Headwinds Justify Avoidance Despite Current Profitability